In patients with hip fracture who are receiving DOACs, a protocol for expedited surgery can be applied in which DOACs are stopped before surgery for at least 48 h for factor Xa inhibitors and according to renal function and up to 96 h after the last dose of dabigatran. This evidence concerns the gene F10 and hip fracture.